reference/23430132

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/23430132

Outgoing Links

Predicate	Object
contentType	Clinical Trial, Phase II\|Journal Article\|Multicenter Study\|Research Support, N.I.H., Extramural\|Research Support, Non-U.S. Gov't
endingPage	404
issn	0360-3016
issueIdentifier	2
pageRange	397-404
publicationName	International journal of radiation oncology, biology, physics
startingPage	397
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_db969213ab8eb35663a5fc0c763e04fb
bibliographicCitation	Kim DW, Blanke CD, Wu H, Shyr Y, Berlin J, Beauchamp RD, Chakravarthy B. Phase II study of preoperative paclitaxel/cisplatin with radiotherapy in locally advanced esophageal cancer. International Journal of Radiation OncologyBiologyPhysics. 2007 Feb;67(2):397–404. doi: 10.1016/j.ijrobp.2006.08.062.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_df781360bc1b73570424779edfdf190c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5d7537018f0dfd6f1828db1961921d65 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_40864a5ff40dc6dbe498a9c8c8bff544 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_13a03b84c8062a4733c99694264f5854 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a5e2551c4489121357c34819f7745e24 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_17bbdfdc303d4ea9a5c381aefcbfddfb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7a462e8d25733eda3dd5ca4b3d654a85
date	2007-02-01^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1016/j.ijrobp.2006.08.062 https://pubmed.ncbi.nlm.nih.gov/17097833
isPartOf	https://portal.issn.org/resource/ISSN/0360-3016 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/4036
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Phase II study of preoperative paclitaxel/cisplatin with radiotherapy in locally advanced esophageal cancer
discusses	http://id.nlm.nih.gov/mesh/M0008631 http://id.nlm.nih.gov/mesh/M0004519 http://id.nlm.nih.gov/mesh/M0004505 http://id.nlm.nih.gov/mesh/M0026156
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D000971Q000627 http://id.nlm.nih.gov/mesh/D004938Q000532 http://id.nlm.nih.gov/mesh/D004938Q000188
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D002294Q000401 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D002955Q000008 http://id.nlm.nih.gov/mesh/D000230Q000401 http://id.nlm.nih.gov/mesh/D000230Q000601 http://id.nlm.nih.gov/mesh/D000230Q000532 http://id.nlm.nih.gov/mesh/D005472Q000008 http://id.nlm.nih.gov/mesh/D000230Q000188 http://id.nlm.nih.gov/mesh/D004938Q000401 http://id.nlm.nih.gov/mesh/D000293 http://id.nlm.nih.gov/mesh/D002945Q000008 http://id.nlm.nih.gov/mesh/D011879 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D004334 http://id.nlm.nih.gov/mesh/D020360Q000379 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D017239Q000008 http://id.nlm.nih.gov/mesh/D002294Q000532 http://id.nlm.nih.gov/mesh/D002294Q000601 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D016629 http://id.nlm.nih.gov/mesh/D002294Q000188 http://id.nlm.nih.gov/mesh/D004938Q000601 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D000704 http://id.nlm.nih.gov/mesh/D005240
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135436482 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5702198 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3385 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID36314 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135403648 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7652

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127952853 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136058681

Showing number of triples: 1 to 68 of 68.